Page last updated: 2024-10-22

amfenac and Chronic Disease

amfenac has been researched along with Chronic Disease in 1 studies

amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sancilio, LF1
Reese, DL1
Cheung, S1
Alphin, RS1

Other Studies

1 other study available for amfenac and Chronic Disease

ArticleYear
AHR-5850: a potent anti-inflammatory compound.
    Agents and actions, 1977, Volume: 7, Issue:1

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Benzophenones; Blood Glucose; Cats; Chronic Diseas

1977